Moderna
MRNA
$43.05
Share price
2.03%
Change (1 day)
-71.14%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Revenue for Moderna (MRNA)
Revenue in 2024 (TTM): S$4.20 Billion
According to Moderna
's latest financial reports the company's current revenue (TTM 
) is S$4.28 Billion. a decrease over the revenue in the year 2023 that were of S$8.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Moderna from 2018 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$4.34 B | -51.25% |
| 2023 | S$8.92 B | -64.75% |
| 2022 | S$25.30 B | 5.53% |
| 2021 | S$23.97 B | 6505.7% |
| 2020 | S$0.36 B | 460.49% |
| 2019 | S$64.76 M | -61.39% |
| 2018 | S$0.16 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |
 | S$85.99 B | 1,905.88% | 🇺🇸 USA |
 | S$0.1 M | -100.00% | 🇺🇸 USA |
 | S$3.01 B | -29.72% | 🇺🇸 USA |
 | S$69.31 B | 1,516.82% | 🇨🇭 Switzerland |
 | S$3.35 M | -99.92% | 🇺🇸 USA |
 | S$119.03 B | 2,676.52% | 🇺🇸 USA |
 | S$0.25 B | -93.97% | 🇺🇸 USA |